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ABSTRACT
Background and study aims The European Society of
Gastrointestinal Endoscopy (ESGE) has defined COVID-19
infection prevention and control strategies within the
endoscopy unit. These include pre-endoscopic question-
naire-based risk-stratification as well as pre-procedure viral
testing. Real-life data on the effectiveness of these meas-
ures are presented here.
Patients and methods Data from the outpatient endo-
scopic unit of the University Hospital Augsburg between
July 1, 2020 and December 31, 2020 including the second
pandemic wave were reviewed retrospectively. All patients
were assessed with a pre-endoscopic risk-stratification
questionnaire as well as viral testing using an antigen
point-of-care test (Ag-POCT) in conjunction with a standard
polymerase chain reaction (PCR) test. Highly elective pro-
cedures were postponed. The theoretically expected num-
ber of SARS-CoV-2-positive patients was simulated and
compared with the actual number. In addition, endoscopy
staff was evaluated with a rapid antibody test to determine
the number of infections among the personnel.
Results In total, 1029 procedures, 591 questionnaires, 591
Ag-POCTs, and 529 standard PCR tests were performed in
591 patients. 247 procedures in 142 patients were post-
poned. One Ag-POCT was positive but with a negative PCR
test, while one PCR test was positive but with a negative Ag-
POCT. This was lower than the theoretically expected num-
ber of COVID-19-positive patients (n =15). One of 43 em-
ployees (2.3%) in the outpatient endoscopy unit was sero-
positive.
Conclusions Pre-endoscopic risk management including
questionnaire-based risk stratification and viral testing
seems to be an effective tool in combination with personal
protective equipment for SARS-CoV-2 infection prevention
and control within the endoscopy unit even in a high-prev-
alence setting.
Supplementary material is available under
https://doi.org/10.1055/a-1526-1169
* These authors contributed equally.
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Introduction
The rapid spread of coronavirus disease 2019 (COVID-19) and
its debilitating impact on health systems has led to a global
health crisis of unprecedented proportions. Health care work-
ers (HCW) exposed to aerosols and tracheobronchial droplets
during gastrointestinal endoscopy are at a higher risk of infec-
tion [1]. In addition, severe acute respiratory syndrome corona-
virus-2 (SARS-CoV-2) has been isolated in the feces of patients
with COVID-19, raising the question of a possible fecal-oral
route of transmission [2].
For these reasons, pre-procedure screening of patients pre-
senting for endoscopy has been suggested in various recom-
mendations [3–5]. Routine pre-endoscopic screening could
have enormous advantages for infection prevention and con-
trol in endoscopic departments. The European Society of Gas-
trointestinal Endoscopy (ESGE) position statements recom-
mend pre-endoscopic risk stratification by questioning for
symptoms and positive history one day before and on the day
of endoscopy [3]. Furthermore, it is recommended that highly
elective examinations may temporarily be postponed. A key
point of the recommended screening strategy is strict viral
testing using molecular diagnostic tests, such as polymerase
chain reaction (PCR), if available. Besides standard PCR, widely
used rapid antigen tests are available for the detection of SARS-
CoV-2 infection. These tests can be performed as an antigen
point-of-care test (Ag-POCT) in the immediate proximity of
the endoscopy unit. However, the position paper does not re-
commend Ag-POCTs due to insufficient data [6].
In the endoscopy unit of Augsburg University Hospital, pre-
procedure risk stratification was performed according to the re-
commendations in the ESGE position statement using a two-
stage pre-procedure questionnaire 1 to 2 days prior to a pa-
tient’s appointment as well as on the day of their presentation
to the endoscopy unit. In addition, especially during the peak of
the second wave in November and December 2020 (Supple-
ment 1), highly elective examinations such as surveillance of
post-polypectomy or post-surgery colorectal cancer patients
were postponed. Besides the standard PCR test, Ag-POCTs
were performed in all patients to generate real-life data for a
prospective evaluation of this test method.
Pre-endoscopic screening procedures are resource-sensitive
and cost-intensive [6]; in addition, data on the effectiveness of
these measures in endoscopic facilities are lacking. In this
study, data on the effectiveness of pre-endoscopic risk man-
agement and testing recommended by ESGE in a high-volume
endoscopic center in Germany during the second wave of the
COVID-19 pandemic are presented.
Patients and methods
Patient screening
We analyzed all outpatients who presented to the endoscopy
unit of the Augsburg University Hospital between 01.07.2020
and 31.12.2020.
Pre-endoscopic risk management was performed according
to the recommendations in the ESGE position statements [3, 7].
For this purpose, patients were screened for COVID-19 using a
two-stage pre-procedure questionnaire for risk stratification, 1
to 2 days prior to their appointment as well as on the day of
their presentation to the endoscopy unit (Supplement 2). After
questionnaire-based risk stratification, patients were tested
with an antigen-POCT (standard F Covid19 Ag FIA/SD; Co. Bio-
sensor). In addition, most patients also underwent a standard
PCR test (see supplemental material). A flowchart showing the
exact procedure in our endoscopy unit is demonstrated in
▶Fig. 1. For the antigen-POCT and the standard PCR test, naso-
pharyngeal or oropharyngeal swabs were taken by appropriate-
ly trained staff members in a separate room of the endoscopy
unit on the day of the procedure. The study was conducted in
accordance with the Declaration of Helsinki and Good Clinical
Practice guidelines. Ethics approval was granted by the Ethics
committee of the Ludwig-Maximilians-Universität München
(EK-Nr. 20-1052).
Simulation of expected COVID-19 case numbers and
number of cancelled or postponed procedures
The catchment area of Augsburg University Hospital was de-
fined using controlling data from previous years. The preval-
ence in the population in the given catchment area was carried
out following Sultan et al. (2020), and a theoretically expected
number of cases of SARS-CoV-2 positive patients was calculat-
ed as follow [8]:
1. The cumulative number of cases was provided by the Bavar-
ian State Office for Health and Food Safety for each day of
the study period.
2. The number of new cases was calculated as a difference be-
tween the cumulative number of cases on the previous day
and the cumulative number of cases on the current /consid-
ered day,
3. Using the daily data from the previous step, the cumulative
number of active cases for the past 14 days was calculated.
4. In line with Forde et al. [9] and Benatia et al. [10], the num-
ber of active cases was adjusted for the SARS-CoV-2 positive
population in the catchment area by multiplying by 10.
5. The population in the catchment area was determined using
information provided by the Bavarian State Office for Health
and Food Safety.
6. The number of expected SARS-CoV-2-positive patients was
determined by dividing the adjusted number of active cases
within the population in the catchment area and multiplying
by the number of patients regularly scheduled in the outpa-
tient's endoscopy unit within the study period.
To obtain the reduction in total case load and an estimate for
the number of examinations cancelled or postponed, we com-
pared the case numbers for the study period with those for the
previous year.
Employee screening
We retrospectively evaluated rapid antibody tests (NADAL COV-
ID-19 IgG/IgM) performed in the last week of the study period
among employees and staff of the endoscopic outpatient de-
partment.
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Results
Examination volume and pre-endoscopic risk
management
The expected examination volume between July and December
2020 estimated using prior-year data was 1276 procedures in
733 patients (▶Fig. 2). A total of 238 procedures in 137 pa-
tients (18.7%) were cancelled between July and December
2020, of which, 185 procedures in 106 patients were cancelled
or postponed during the peak of the second wave of the pan-
demic in November and December.
Examinations and procedures were cancelled or postponed
due to COVID-19-like symptoms, a positive history in the pre-
endoscopic screening questionnaire, or due to a highly elective
indication. A total of 596 patients (81.3%) with 1038 planned
procedures presented to the endoscopy unit and underwent
pre-endoscopic risk stratification in the endoscopy unit. Five
patients (1.0%) were sent home without further testing or in-
tervention on the day of pre-procedure screening due to high-
risk stratification according to the questionnaire. Two of them
had recently travelled to a high-risk area and three of them
had COVID-19-related symptoms.
A total of 591 patients were tested with the Ag-POCT, of
which, 529 (89.5%) received a standard PCR test in parallel.
The antigen test provided a result within 20 minutes, while the
results of the standard PCR test were available with a time delay
of up to 24 hours.
Of the 1029 procedures performed, 636 (61.8%) were en-
doscopies of the upper gastrointestinal tract (543 gastrosco-
pies, 1 endoscopic retrograde cholangiopancreatography, 92
endoscopic ultrasounds).
Results of the Ag-POCT
Ag-POCT was positive in one patient (0.2%) but with a negative
standard PCR test while one other patient tested positive with
standard PCR test but negative in the Ag-POCT. However, this
patient had a high cycle threshold (CT) value of 35.6.
Expected COVID-19 case number
The simulations were performed as described in the methods
section. The expected case number of SARS-CoV-2 positive pa-
tients for the study period was 15.
Strategy
Before the appointment
Patients are contacted by telephone one to 
two days prior to presentation to our clinic. 
A risk-stratification questionnaire is completed 
via telephone
Patient presenting in the endoscopy unit
Completion of the questionnaire on 
symptoms / recent contacts to COVID-19 
infected persons / current quarantine/
stay abroad
POCT-antigen test (result within 20 minutes) + 









Negative POCT but 






In high prevalence phase of the pandemic, 
performance of the endoscopy with high-risk PPE
Negative POCT result
Performance of the endoscopy with 




questionnaire / positive test result
Post-contact tracing
▪ Contact the patient
▪ Retrace all contacts the patient had within 
 the hospital
▪ Inform the public health agency
Re-appoint after 
quarantine/clarification etc.
▶ Fig. 1 Screening strategy in the endoscopy unit for outpatients. Ag-POCT, antigen point-of-care test; COVID-19, corona virus disease 2019;
PCR, polymerase chain reaction; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
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Employee screening
Fourty-three employees/health care workers in the endoscopy
department underwent an antibody rapid test. One endoscopy
nurse had a positive result while 42 were negative. All workers
were asymptomatic on the day of the test.
Discussion
In this paper, we present real-life data on the effectiveness of
pre-endoscopic risk management according to the recommen-
dations of the ESGE in a high-volume endoscopic center in Ger-
many during the second wave of the COVID-19 pandemic.
The study was conducted in Augsburg which has been a local
hotspot during the ongoing second wave of the pandemic. Sev-
en-day incidence rates as high as 400 per 100,000 were report-
ed for the region [11].
The calculated number of expected SARS-CoV-2-positive pa-
tients, taking into account the daily prevalence in the catch-
ment area, was 15. This number is in contrast to the one patient
who tested positive via PCR test. We believe the reason for the
low number of detected cases was the strict questionnaire-
based risk stratification performed via telephone, 1 to 2 days
prior to the intervention, as well as on the day of the interven-
tion. It is also possible that the temporary postponement of
highly elective procedures may have resulted in a decreased
number of SARS-CoV-2-positive patients presenting to the
endoscopy unit. According to the simulation based on the prev-
alence and incidence rates in the region, about 14 additional
patients with COVID-19 should have presented to the unit.
However, the estimated number of unreported cases in Germa-
ny seems to be overestimated with a factor of 10.Other sources
suggest a factor of three to five [12, 13]. In this case, however,
there would still have been an expected five to eight patients
instead with a SARS-CoV-2 infection.
With only one positive PCR test result and one positive result
in the Ag-POCT, it is not possible to correctly estimate the sen-
sitivity and specificity of the Ag-POCT. The patient who tested
positive in the Ag-POCT had a negative PCR test. The patient
had previously been tested positive several times in the Ag-
POCT. However, the PCR test had always been negative and
there was no history of previous disease. For this reason, we as-
sume the Ag POCT to have been false positive in this case pre-
sumably due to bacterial colonization [14]. In the PCR test-po-
sitive patient, the CT value was 35.6, which implies a low phar-
yngeal viral load [15]. Because the PCR test result was received
about 24 hours later, all health care workers involved in the di-
rect care of this patient underwent clinical follow-up and test-
ing but remained negative and asymptomatic. After receiving
the positive PCR test result, the patient was sent to home isola-
tion according to the orders of the local health department.
However, the patient did not have any COVID-19 typical symp-
toms at any time.
A further indication for the effectiveness of the risk-man-
agement measures is the low number of infected employees
within the unit. Only one endoscopy worker (2.3%) had a sero-
logically detectable history of past infection, which had been
acquired within the private family environment. Of course, all
recommended personal protective equipment (PPE) standards
were used routinely for all endoscopy procedures irrespective
of the pre-endoscopy risk-stratification.
Our findings are in line with publications by Recipi et al. and
Hayee et al., who described the use of PPE and reduction of
elective procedures as a useful tool for SARS-CoV-2 infection
prevention [16, 17].
The Ag-POCT, which was part of our study evaluation, is
cheap, widely available, easily performable at the point-of-
care, and produces results within 20 minutes [18]. However,
real-life data on test accuracy in endoscopy units are lacking.
Nevertheless, Ag-POCT may be considered in combination
with questionnaire-based risk-stratification and use of the re-
commended PPE for units without access to the resource-inten-
sive and significantly more expensive molecular diagnostic PCR
test. The approval of COVID-19 vaccines in the last few months,
Based on the ESGE position statement [3, 7], 
238 procedures in 137 patients were cancelled 
or postponed due to symptoms or a positive 
history in the pre-endoscopy screening questi-
onnaire, by
5 (1%) patients were excluded from 
9 procedures due to COVID-19 related 
symptoms or positive history
1 positive Ag-POCT that was interpreted 
false positive based on the patient’s 
history
1 positive standard PCR test 
(result received after the procedure)
733 patients with 1276 endoscopic procedures
596 (81%) patients with 1038 planned procedures 
presenting in the endoscopy unit
Completion of the questionnaire on symptoms/recent 
contacts to SARS-CoV-2 infected persons/current
591 (99%) patients with planned endoscopic procedures
591 (100%) patients underwent Ag-POCT + 529 (90 %) 
underwent standard PCR test
591 (100%) patients with 1029 performed 
endoscopic procedures
▶ Fig. 2 Screening data for the study period. Ag-POCT, antigen
point-of-care-test; COVID 19, corona virus disease 2019 ESGE,
European Society of Gastrointestinal Endoscopy; PCR, polymerase
chain reaction; SARS-CoV-2, severe acute respiratory syndrome
coronavirus 2.
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and the widespread vaccination of endoscopy health care work-
ers, may require an adjustment of the recommendations pres-
ented in this study.
The major limitation of this study is the retrospective evalu-
ation, which made it difficult to evaluate the exact number of
patients whose procedures were cancelled specifically due to a
high-risk stratification via telephone. However, most elective
endoscopic examinations were continued during the second
wave of the pandemic, which means that a greater number of
cancelled or postponed procedures can be attributed to a
high-risk stratification according to the questionnaire.
A further limitation is the low number of SARS-CoV-2-posi-
tive PCR test results (n =1) produced during the study period,
making the planned direct prospective comparison between
the Ag-POCT and PCR tests impossible. However, and as de-
scribed above, the low number of positive patients can be at-
tributed to the risk-stratification approach described above.
Conclusions
In conclusion, pre-endoscopic risk management recommended
by ESGE, especially questionnaire-based risk stratification in
conjunction with viral testing, seems to be an effective tool in
combination with PPE for SARS-CoV-2 infection prevention
and control within the endoscopy unit even in a high-preval-
ence setting.
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